Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe

被引:17
作者
Bozdogan, B
Appelbaum, PC
Kelly, LM
Hoellman, DB
Tambic-Andrasevic, A
Drukalska, L
Hryniewicz, W
Hupkova, H
Jacobs, MR
Kolman, J
Konkoly-Thege, M
Miciuleviciene, J
Pana, M
Setchanova, L
Trupl, J
Urbaskova, P
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA
[2] Univ Zagreb, Univ Hosp Infect Dis, Zagreb, Croatia
[3] Med Acad Latvia, Childrens Hosp, Riga, Latvia
[4] Sera & Vaccine Lab, Warsaw, Poland
[5] St Cyril & Method Hosp, Bratislava, Slovakia
[6] Case Western Reserve Univ, Cleveland, OH 44106 USA
[7] Univ Ljubljana, Ljubljana, Slovenia
[8] Natl Ctr Epidemiol, Budapest, Hungary
[9] Kaunas Med Univ Hosp, Kaunas, Lithuania
[10] Inst Cantacuzino, Bucharest, Romania
[11] Acad Med Sofia, Hosp Infect Dis, Sofia, Bulgaria
[12] Natl Canc Inst, Bratislava, Slovakia
[13] Natl Antibiot Reference Lab, Prague, Czech Republic
关键词
telithromycin; Streptococcus pyogenes; macrolide resistance;
D O I
10.1046/j.1469-0691.2003.00598.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In total, 1039 pediatric Streptococcus pyogenes isolates from Bulgaria, Croatia, the Czech Republic, Hungary, Latvia, Lithuania, Poland, Romania, Slovakia and Slovenia were studied. All strains were susceptible to penicillin G, levofloxacin, and quinupristin-dalfopristin, 91-100% to telithromycin, and 82-100% to erythromycin, azithromycin, and clarithromycin, and 90-100% to clindamycin. Macrolide resistance occurred mainly in Slovakia (25%), the Czech Republic (17.3%), and Croatia (15.8%). Overall, 9.7% of S. pyogenes isolates were erythromycin resistant due to erm(B) - or erm(A) -encoded methylases (72.3%) or to a mef(A) -encoded efflux pump (25.7%). One strain had alterations of both 23S rRNA (A2058G Escherichia coli numbering) and ribosomal protein L22 (G95D).
引用
收藏
页码:741 / 745
页数:5
相关论文
共 19 条
[1]   High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes:: results of a Spanish multicentre study in 1998 [J].
Alós, JI ;
Aracil, B ;
Oteo, J ;
Torres, C ;
Gómez-Garcés, JL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (05) :605-609
[2]  
[Anonymous], J CLIN MICROBIOL
[3]   Carriage of antibiotic-resistant Streptococcus pneumoniae by children in Eastern and Central Europe - A multicenter study with use of standardized methods [J].
Appelbaum, PC ;
Gladkova, C ;
Hryniewicz, W ;
Kojouharov, B ;
Kotulova, D ;
Mihalcu, F ;
Schindler, J ;
Setchanova, L ;
Semina, N ;
Trupl, J ;
Tyski, S ;
Urbaskova, P ;
Jacobs, MR .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :712-717
[4]   Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients [J].
Bingen, E ;
Fitoussi, F ;
Doit, C ;
Cohen, R ;
Tanna, A ;
George, R ;
Loukil, C ;
Brahimi, N ;
Le Thomas, I ;
Deforche, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1453-1457
[5]   Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes [J].
Clancy, J ;
Petitpas, J ;
DibHajj, F ;
Yuan, W ;
Cronan, M ;
Kamath, AV ;
Bergeron, J ;
Retsema, JA .
MOLECULAR MICROBIOLOGY, 1996, 22 (05) :867-879
[6]   Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy [J].
Cornaglia, G ;
Ligozzi, M ;
Mazzariol, A ;
Masala, L ;
Lo Cascio, G ;
Orefici, G ;
Fontana, R .
CLINICAL INFECTIOUS DISEASES, 1998, 27 :S87-S92
[7]   Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents [J].
Ednie, LM ;
Spangler, SK ;
Jacobs, MR ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1033-1036
[8]   Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains [J].
Giovanetti, E ;
Montanari, MP ;
Mingoia, M ;
Varaldo, PE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :1935-1940
[9]   Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes [J].
Jasir, A ;
Schalén, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) :135-137
[10]   Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations [J].
Malbruny, B ;
Nagai, K ;
Coquemont, M ;
Bozdogan, B ;
Tambic Andrasevic, A ;
Hupkova, H ;
Leclercq, R ;
Appelbaum, PC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (06) :935-939